{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:30:55Z","timestamp":1793712655110,"version":"4.6.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jogc.2023.04.008","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T15:16:55Z","timestamp":1685027815000},"page":"417-429.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Guideline No. 437: Diagnosis and Management of Adenomyosis"],"prefix":"10.1016","volume":"45","author":[{"given":"E. Shirin","family":"Dason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalina","family":"Maxim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Papillon-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2023.04.008_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.fertnstert.2018.01.006","article-title":"Symptoms and classification of uterine adenomyosis, including the place of hysteroscopy in diagnosis","volume":"109","author":"Gordts","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.04.008_bib2","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1093\/humrep\/des332","article-title":"How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic","volume":"27","author":"Naftalin","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2023.04.008_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/uog.14834","article-title":"Transvaginal sonographic features of diffuse adenomyosis in 18\u201330-year-old nulligravid women without endometriosis: association with symptoms","volume":"46","author":"Pinzauti","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.04.008_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12958-016-0185-6","article-title":"Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease","volume":"14","author":"Puente","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.jogc.2023.04.008_bib5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/uog.15798","article-title":"Association between ultrasound features of adenomyosis and severity of menstrual pain","volume":"47","author":"Naftalin","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.04.008_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/humrep\/det451","article-title":"Is adenomyosis associated with menorrhagia?","volume":"29","author":"Naftalin","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2023.04.008_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.rbmo.2020.09.023","article-title":"Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis","volume":"42","author":"Nirgianakis","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jogc.2023.04.008_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jmig.2019.11.013","article-title":"Classification and reporting systems for adenomyosis","volume":"27","author":"Munro","year":"2020","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2023.04.008_bib9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/uog.19096","article-title":"Sonographic classification and reporting system for diagnosing adenomyosis","volume":"53","author":"Van den Bosch","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2023.04.008_bib10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.fertnstert.2018.06.009","article-title":"Development of a clinical prediction model for diagnosing adenomyosis","volume":"110","author":"Tellum","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.04.008_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.fertnstert.2018.01.024","article-title":"Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis","volume":"109","author":"Bazot","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.04.008_bib12","first-page":"98","article-title":"Current diagnosis and management of adenomyosis in Canada: a survey of Canadian gynaecologists","volume":"14","author":"Maxim","year":"2022","journal-title":"J\u00a0Endometr Pelvic Pain Disord"},{"key":"10.1016\/j.jogc.2023.04.008_bib13","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/jum.15237","article-title":"Question mark sign and transvaginal ultrasound uterine tenderness for the diagnosis of adenomyosis: a prospective validation","volume":"39","author":"Zannoni","year":"2020","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.jogc.2023.04.008_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jmig.2020.10.012","article-title":"A\u00a0systematic review of adenomyosis: it is time to reassess what we thought we knew about the disease","volume":"28","author":"Loring","year":"2021","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2023.04.008_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejogrb.2021.05.013","article-title":"Uterine involvement by endometriosis: sonographic features from elusive findings to apparent adenomyosis","volume":"262","author":"Olgan","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogc.2023.04.008_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jmig.2017.08.653","article-title":"Transvaginal ultrasound for the diagnosis of adenomyosis: systematic review and meta-analysis","volume":"25","author":"Andres","year":"2018","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2023.04.008_bib17","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2021\/e2981","article-title":"Association of 2D and 3D transvaginal ultrasound findings with adenomyosis in symptomatic women of reproductive age: a prospective study","volume":"76","author":"Marques","year":"2021","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.jogc.2023.04.008_bib18","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3109\/00016349.2010.512061","article-title":"Ultrasound scan and magnetic\u00a0resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy","volume":"89","author":"Champaneria","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2023.04.008_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/aogs.14139","article-title":"Objective measures of adenomyosis on MRI and their diagnostic accuracy-a systematic review & meta-analysis","volume":"100","author":"Rees","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2023.04.008_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1148\/rg.311105110","article-title":"Adenomyosis: usual and unusual imaging manifestations, pitfalls, and problem-solving MR imaging techniques","volume":"31","author":"Takeuchi","year":"2011","journal-title":"RadioGraphics"},{"key":"10.1016\/j.jogc.2023.04.008_bib21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jmig.2019.09.001","article-title":"A\u00a0systematic review of tissue sampling techniques for the diagnosis of adenomyosis","volume":"27","author":"Movilla","year":"2020","journal-title":"J\u00a0Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2023.04.008_bib22","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/humrep\/dem084","article-title":"Laparoscopy-guided myometrial biopsy in the definite diagnosis of diffuse adenomyosis","volume":"22","author":"Jeng","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2023.04.008_bib23","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.jogc.2018.03.007","article-title":"No. 292-abnormal uterine bleeding in pre-menopausal women","volume":"40","author":"Singh","year":"2018","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.04.008_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.fertnstert.2010.10.009","article-title":"Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis","volume":"95","author":"Ozdegirmenci","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.04.008_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.contraception.2015.05.015","article-title":"Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial","volume":"92","author":"Shaaban","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2023.04.008_bib26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/aogs.13798","article-title":"The role of levonorgestrel intra-uterine system in the management of adenomyosis: a systematic review and meta-analysis of prospective studies","volume":"99","author":"Abbas","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2023.04.008_bib27","article-title":"Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis","volume":"99","author":"Song","year":"2020","journal-title":"Med (Baltim)"},{"key":"10.1016\/j.jogc.2023.04.008_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ijgo.12887","article-title":"Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system","volume":"146","author":"Li","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogc.2023.04.008_bib29","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.21037\/atm-20-3420","article-title":"Efficacy of the levonorgestrel-releasing intrauterine device is associated with different subtypes of adenomyosis: a retrospective study","volume":"8","author":"Chen","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jogc.2023.04.008_bib30","first-page":"907","article-title":"A\u00a0randomized, double-blind, multicenter, placebo-controlled study of dienogest in the treatment of painful symptoms in patients with adenomyosis in Japan","volume":"45","author":"Osuga","year":"2017","journal-title":"Jpn Pharmacol Ther"},{"key":"10.1016\/j.jogc.2023.04.008_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ijgo.13600","article-title":"Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: a randomized clinical trial","volume":"154","author":"Hassanin","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogc.2023.04.008_bib32","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/jog.14612","article-title":"Evaluating the safety of dienogest in women with adenomyosis: a retrospective analysis","volume":"47","author":"Ono","year":"2021","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.jogc.2023.04.008_bib33","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/jog.13674","article-title":"Long-term dienogest administration in patients with symptomatic adenomyosis","volume":"44","author":"Neriishi","year":"2018","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.jogc.2023.04.008_bib34","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/ph5101120","article-title":"Norethindrone acetate in the medical management of adenomyosis","volume":"5","author":"Muneyyirci-Delale","year":"2012","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jogc.2023.04.008_bib35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fertnstert.2018.01.013","article-title":"Role of medical therapy in the management of uterine adenomyosis","volume":"109","author":"Vannuccini","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.04.008_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/GMIT.GMIT_35_18","article-title":"Efficacy of hormonal therapies for decreasing uterine volume in patients with adenomyosis","volume":"7","author":"Matsushima","year":"2018","journal-title":"Gynecol Minim Invasive Ther"},{"key":"10.1016\/j.jogc.2023.04.008_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ijgo.13341","article-title":"Triptorelin for the treatment of adenomyosis: a multicenter observational study of 465 women in Russia","volume":"151","author":"Andreeva","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogc.2023.04.008_bib38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/09513590.2019.1683818","article-title":"Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest","volume":"36","author":"Matsushima","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jogc.2023.04.008_bib39","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.17242.1","article-title":"Recent advances in understanding and managing adenomyosis","volume":"8","author":"Vannuccini","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.jogc.2023.04.008_bib40","article-title":"Efficacy of long-term, low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for adenomyosis","volume":"15","author":"Akira","year":"2009","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jogc.2023.04.008_bib41","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.fertnstert.2020.04.017","article-title":"Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis","volume":"114","author":"Donnez","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.04.008_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5301\/je.5000270","article-title":"Long-term vaginal danazol treatment in fertile age women with adenomyosis","volume":"9","author":"Tosti","year":"2017","journal-title":"J\u00a0Endometriosis Pelvic Pain Disord"},{"key":"10.1016\/j.jogc.2023.04.008_bib43","article-title":"Ulipristal acetate use in adenomyosis: a randomized controlled trial","volume":"50","author":"Capmas","year":"2021","journal-title":"J\u00a0Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.jogc.2023.04.008_bib44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1600-0412.2012.01350.x","article-title":"Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial","volume":"91","author":"Badawy","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2023.04.008_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0040-1718921","article-title":"Current and future surgical and interventional management options for adenomyosis","volume":"38","author":"Chen","year":"2020","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.jogc.2023.04.008_bib46","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jvir.2017.07.034","article-title":"Uterine artery embolization for the treatment of adenomyosis: a systematic review and meta-analysis","volume":"28","author":"de Bruijn","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jogc.2023.04.008_bib47","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.2196\/resprot.8512","article-title":"Uterine artery embolization\u00a0versus hysterectomy in the treatment of symptomatic adenomyosis: protocol for the randomized QUESTA trial","volume":"7","author":"de Bruijn","year":"2018","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.jogc.2023.04.008_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165610","article-title":"Outcomes in adenomyosis treated with uterine artery embolization are associated with lesion vascularity: a long-term follow-up study of 252 cases","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2023.04.008_bib49","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00270-011-0203-1","article-title":"Long-term follow-up of uterine artery embolization for symptomatic adenomyosis","volume":"35","author":"Smeets","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jogc.2023.04.008_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejogrb.2018.04.001","article-title":"Evaluation of NovaSure\u00ae global endometrial ablation in symptomatic adenomyosis: a longitudinal study with a 36 month follow-up","volume":"227","author":"Philip","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogc.2023.04.008_bib51","first-page":"136","article-title":"[The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis]","volume":"48","author":"Lou","year":"2019","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.jogc.2023.04.008_bib52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.fertnstert.2018.01.032","article-title":"Uterine adenomyosis and adenomyoma: the surgical approach","volume":"109","author":"Osada","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.04.008_bib53","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jogc.2018.12.006","article-title":"No. 377-hysterectomy for\u00a0benign\u00a0gynaecologic indications","volume":"41","author":"Thurston","year":"2019","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2023.04.008_bib54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5935\/1518-0557.20200104","article-title":"Adenomyosis and in\u00a0vitro fertilization impacts - A literature review","volume":"25","author":"Squillace","year":"2021","journal-title":"JBRA Assist Reprod"},{"key":"10.1016\/j.jogc.2023.04.008_bib55","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.fertnstert.2017.06.025","article-title":"Effects of adenomyosis on in\u00a0vitro fertilization\u00a0treatment outcomes: a meta-analysis","volume":"108","author":"Younes","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2023.04.008_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.rbmo.2019.03.101","article-title":"Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis","volume":"39","author":"Liang","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jogc.2023.04.008_bib57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5653\/cerm.2016.43.3.169","article-title":"Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment","volume":"43","author":"Park","year":"2016","journal-title":"Clin Exp Reprod Med"},{"key":"10.1016\/j.jogc.2023.04.008_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.609771","article-title":"Ultra-long GnRH agonist protocol during IVF\/ICSI improves pregnancy outcomes in women with adenomyosis: a retrospective cohort study","volume":"12","author":"Lan","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jogc.2023.04.008_bib59","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3109\/09513590.2013.824960","article-title":"Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis","volume":"29","author":"Niu","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"10.1016\/j.jogc.2023.04.008_bib60","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/humrep\/deu041","article-title":"Uterine adenomyosis and in vitro fertilization outcome: a systematic review\u00a0and meta-analysis","volume":"29","author":"Vercellini","year":"2014","journal-title":"Human Reproduction [Internet]"},{"key":"10.1016\/j.jogc.2023.04.008_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoy011","article-title":"The rate of euploid miscarriage is increased in the setting of adenomyosis","volume":"2018","author":"Stanekova","year":"2018","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.jogc.2023.04.008_bib62","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.rbmo.2017.06.026","article-title":"The impact of adenomyosis on the outcome of IVF-embryo transfer","volume":"35","author":"Mavrelos","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jogc.2023.04.008_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.rbmo.2018.09.014","article-title":"Does presence of adenomyosis affect reproductive outcome in IVF cycles? A retrospective analysis of 973 patients","volume":"38","author":"Sharma","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.jogc.2023.04.008_bib64","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoab015","article-title":"The impact of adenomyosis on IVF outcomes: a prospective cohort study","volume":"2021","author":"Higgins","year":"2021","journal-title":"Hum Reprod Open"},{"issue":"3","key":"10.1016\/j.jogc.2023.04.008_bib65","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.fertnstert.2022.12.021","article-title":"Pregnancy outcomes with donor oocyte embryos in patients diagnosed with adenomyosis using the Morphological Uterus Sonographic Assessment criteria","volume":"119","author":"Dason","year":"2023","journal-title":"Fertility and Sterility [Internet]"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216323003079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216323003079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:42:29Z","timestamp":1761666149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216323003079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1701216323003079"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2023.04.008","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline No. 437: Diagnosis and Management of Adenomyosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2023.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}